Polycystic Ovarian Syndrome (PCOS) in Adolescence

 

Dr. Mrs. S. Anuchithra Radhakrishnan,

Vice Principal and HOD, OBG Nursing, P.D. Bharatesh College of Nursing, Halaga, Belgaum, Karnataka.

*Corresponding Author Email: anuchithra7377@yahoo.co.in

 


INTRODUCTION:

Follicles of the ovary are the basic unit of female reproductive biology. They are usually round and contain a single egg or ovum. Normal ovarian volume in the menstruating females is 5-15 mL, with an approximate mean of 10 ml.  Polycystic ovary syndrome (PCOS) is the leading cause of menstrual irregularities and hyperandrogenism in adolescents. In   addition, it is the most common hormonal disorder in obesity and one of the most common causes of infertility in women. Although it was traditionally thought to be a problem of adulthood, it is now known that its onset takes place in childhood. It should be considered in any adolescent with hirsutism, persistent acne, dysfunctional uterine bleeding and/or obesity.

 

The identification of each of these complaints is a challenge in adolescence. On the other hand, diagnosis of PCOS has long term implications with increased risk of infertility, metabolic syndrome, type2 diabetes (T2DM) and cardiovascular disease. Increasing prevalence of obesity in adolescence has generated a growing concern with the increase of PCOS at this age. Although obesity is not a feature of the syndrome, it affects the degree of insulin resistance, worsening metabolic and reproductive characteristics.

 

There is strong evidence that obesity increase severity of clinical manifestations of PCOS and the risk of metabolic dysfunction. In adolescents, as in adult women, there is a positive association between body mass index (BMI) and androgen levels. On the other hand, weight loss is associated with a decrease in testosterone.

 

 

Increase in child hood obesity worsens the symptoms of PCOS in adolescence, although it is unlikely that it increases the prevalence of this syndrome. In other words, obesity seems to unmask young people who were otherwise asymptomatic and are now presenting with symptoms of androgen excess and anovulation. Long-term monitoring of women with PCOS revealed that 40% of those affected develop type2 diabetes or impaired glucose tolerance at the age of 40. The risk of developing type 2 diabetes is 10 times higher in patients with PCOS, which represents a public health problem and an opportunity for early intervention.

 

Nomenclature:

Other names of PCOS are;

·         Polycystic ovary disease,

·         Functional ovarian hyperandrogenism,

·         Hyperandrogenic chronic anovulation,

·         Ovarian dysmetabolic syndrome,

·         Polycystic ovarian syndrome

·         Stein-Leventhal syndrome.

Definition of PCOS in Adolescence:

Under the criteria of the National Institutes of Health (NIH), PCOS was defined as the presence of oligoovulation /anovulation and clinical or biochemical hyperandrogenism, not explained by other causes.  2003, a new consensus between the European Society of Human Reproduction and Embryology and the American Society of Reproductive Medicine established the Rotterdam criteria, defining PCOS when at least 2 of these 3 criteria are present, after exclusion of other diseases as with similar phenotypes.

 

Rotterdam

 

Rotterdam diagnostic criteria requires two of;

1.  Oligo or anovulation;

2.  Clinical and/or biochemical signs of hyperandrogenism;

3.  Plycystic ovaries;

and exclusion of other aetiologies such as hypothyroidism, hypoprolactinemia, congenital adrenal hyperplasia, androgen – secreting tumors and cushing’s syndrome (14)

 

NIH

 

 

NIH diagnostic criteria requires;

1.      Oligo or anovulation; and

2.      Clinical and/or biochemical signs of hyperandrogenism;

And exclusion of other aetiologies such as congenital adrenal hyperplasia, angrogen-secreting tumours and Cushing’s syndrome (15).

 

 

 

 

 

 

There are no diagnostic criteria specifically defined for adolescence, when physiological and anatomical changes make this diagnosis a challenge. First, it is difficult to distinguish between physiological an ovulation often found in puberty and an ovulation of PCOS. In healthy adolescents, half of the cycles are an ovulatory in the first year after menarche. Secondly, the definition of polycystic ovary in adolescence is difficult. The frequent occurrence of multiple follicles during adolescence may be misleading with the appearance of multicystic ovaries, a normal adolescent variant.  Furthermore, the use of abdominal instead of transvaginal route in teenage virgins decreases sensitivity of ultrasound.  Finally, a slight acne and hirsutism are common and there might be a transient functional hyperandrogenism during adolescence.

 

Incidence:

Rounded Rectangle: Polycystic ovaries are present in 3-7% of women worldwide
 

 

 

 


PCOS or Polycystic ovarian syndrome is a heterogeneous complex metabolic, endocrine, reproductive disorder. Most studies note that polycystic ovaries are present in 3-7% of women worldwide. In India it is estimated that the incidence is higher and probably three times more than that found in the western world. PCOS affecting 9.13% Indian adolescents, about 2.2% to 26% women in the age range of 18 to 45 years in India. PCOS can be a frustrating experience for women, a complex syndrome for clinicians and a scientific challenge for researchers, and is a major public health concern.

 

Polycystic ovarian syndrome (PCOS) accounts for – 90% of women with infrequent periods (or oligomenorrhea), 30% of women with absence of periods (or amenorrhea) and Over 70% of women with anovulation – no production of eggs during periods.

 

Medscape

PCOS: changing women’s health paradigm

 

 

                                                                        Metabolic disease

Reproductive disorders

(Young age)

 

(Older age)

Menstrual disorder

Hirsutism

Contraception

Sexual health

Infertility

à

Pregnancy complications

Quality of life

Type 2 diabetes

Cardiovascular disease

Cancer risk

 

Multi – disciplinary approaches

 

Pediatrics

à

Dermatology

à

Gynecology

à

Endocrinology

à

Diabetology

à

Cardiology

à

Geriatry

Source: Hum Reprod @ 2011 Oxford University Press

 

Schematic representation of the change in emphasizes from early age reproductive disorders to long-term metabolic and cardiovascular health.

 

Normal physiology and Mechanism:

 

Rounded Rectangle: Mechanism of polycystic ovarian syndrome is due to hormonal imbalance.
 

 

 


The hormones in human bodies are regulated by two regions of the brain – the hypothalamus and the pituitary gland. Hormones are chemicals that are secreted in miniscule amounts and a very small imbalance in their secretions can lead to different problems that can manifest as diseases.

 

Understanding the cause of polycystic ovaries requires some basic understanding of how the hormones are normally regulated. In the normal physiology / state

 

Hypothalamus

Gonadotropin-releasing hormone (GnRH), Luteinizing hormone (LH) and Follicle-Stimulating Hormone (FSH) from the pituitary gland, acts on certain cells of the ovary.

 

Estrogen and progesterone, the female sex hormones (and also make a little bit of the androgen testosterone, a male sex hormone).

 

Bring about maturation of the follicle and results in release of eggs.

 

The pancreas is an organ that makes the hormone insulin. High levels of insulin can also cause the ovaries to make more of the hormone testosterone.

 

Review of Regular Menstrual Cycle:

1.       The menstrual cycle starts when the brain sends LH and FSH to the ovaries. A big surge of LH is the signal that tells the ovaries to ovulate, or release an egg.

2.       The egg travels down the fallopian tube and into the uterus. Progesterone from the ovary tells the lining of the uterus to thicken.

3.       If the egg isn't fertilized, the lining of the uterus is shed. This is a menstrual period.

4.       After the menstrual period, the cycle begins all over again.

 

PCOS Cycle with no Ovulation:

Girls with PCOS may ovulate occasionally or not at all, so periods may be too close together, or more commonly too far apart. Some girls may not get a period at all.

 

In polycystic ovaries syndrome, the cycle is disturbed. Evaluation of blood serum levels typically reveals elevated LH levels and normal or low FSH levels. Patients also have increased levels of free estrogen (primarily estrone and estradiol) and testosterone levels.

 

The lack of follicle maturation and the inability to ovulate are likely caused by low levels of follicle stimulating hormone (FSH) , and higher-than-normal levels of androgens (male hormones), produced in the ovary.

 

1.       With PCOS, LH levels are often high when the menstrual cycle starts. The levels of LH are also higher than FSH levels.

2.       Because the LH levels are already quite high, there is no LH surge. Without this LH surge, ovulation does not occur, and periods are irregular

Causes:

Rounded Rectangle: The proposed causes of polycystic ovarian syndrome are numerous and may, in fact, be multiple. 

 


The proposed causes of polycystic ovaries are briefly listed below:

·         Ovary hormones

·         Increased androgen production

·         Disturbances in the cyclic pattern of GnRH release by the hypothalamus

·         Insulin resistance

·         Autosomal dominant transmission

 

a. Ovary hormones:

Hormones are not in adequate levelsLack of maturation of follicle

Inability to ovulate.

 

b. Increased androgen production: The adrenal glands at puberty Increased androgen.High androgen levels in a woman causes hirsutism and acne problems and can stop ovulation.

 

c. Disturbances in the cyclic pattern of GnRH release by the hypothalamus

 

d. Insulin resistance: Inadequate response to insulin can lead to abnormally elevated blood sugar (glucose) levels. The insulin disturbance is also being the trigger for the development of symptoms such as acne and excess hair growth that is seen with PCOS.

 

e. Autosomal dominant transmission: There is not yet enough evidence to say there is a genetic link to this disorder. Women with PCOS frequently have a familial history of PCOS.

 

The etiological, hormonal and clinical features of polycystic ovary syndrome are;

 

Pathophysiology:

PCOS seems to be a malfunction with ovarian overproduction of androgens in genetically determined women. The heterogeneity of clinical manifestations may be explained by interaction of the disease with environment, mainly diet. The genesis of PCOS appears to begin much earlier than in adolescence, possibly even in intrauterine life. One of the early manifestations of PCOS can be premature pubarche (appearance of pubic hair before 8 years old).

 

A low weight at birth and a rapid recovery (catch-up) of weight in early life are associated with an increased risk of premature pubarche and precocious puberty. Among girls with pre- mature pubarche, those with a history of low birth weight, even if not obese, have the greatest hyperinsulinism and a greater risk of developing a variant of PCOS with hyper- insulinemic hyperandrogenism, dyslipidemia and central obesity.

 

The complete clinical syndrome is manifested with maturation of the hypothalamic–pituitary–ovary axis that occurs in puberty. The increase of LH circulating levels, characteristic of puberty, is exaggerated in girls with predisposition for PCOS, increasing the production of androgens by the ovary. The presentation in adolescence is also affected by metabolic changes associated with body fat distribution.

 

The hyperinsulinism leads to suppression of hepatic production of SHBG, which amplifies the effects of steroid hormones, with higher free testosterone concentrations.

 

Maturation of the hypothalamic–pituitary–ovary axis in puberty.

 

LH circulating levels (characteristic of puberty), is exaggerated in girls with PCOS,

 

Production of androgens by ovary.

Metabolic changes associated with body fat distribution

 

Higher insulin resistance

Hyperinsulinism

 

Suppression of hepatic production of Sex Hormone -Binding- Globulin ( SHBG- glycol protein binds to sex hormone, to be specific-Testosterone, Estradiol, Progesterone, Cortisol and Corticosteroids are bound by trans scartin) (which amplifies the effects of steroid hormones, with higher free testosterone concentrations)

 

In addition, insulin increases steroidogenic response of thecal cells to luteinizing hormone (LH), stimulating the production of ovarian androgens.

 

Normal puberty and adolescence are associated with increased insulin resistance and increased fasting insulin concentrations. Women with PCOS, whether lean or obese, have higher insulin resistance than women without PCOS of similar weight. Furthermore, studies show worsening of insulin resistance with overweight and obesity associated with PCOS. The main source of hyperandrogenemia in PCOS is the ovary. Abnormally high levels of insulin, either by genetic predisposition or by excessive weight gain, or both, will increase these potential adverse effects. Despite a state of insulin resistance in other tissues, ovarian steroidogenic response to insulin is maintained.

 

Clinical Features PCOS:

Rounded Rectangle: Women with polycystic ovary syndrome may display a wide range of clinical symptoms 

 

 


In PCOS, symptoms start slowly and progressively. In adolescence can manifest in different forms, including hirsutism, menstrual irregularity, acanthosis nigricans (Thickened brown velvety textured patches of skin that may occur in any location but most commonly appear in the folds of the skin in the armpit, groin and back of the neck) and precocious pubarche and / or puberty.

 

 

Moreover, persistent acne or hair loss can be the main complaints of these adolescents. Sudden appearance and rapid progression of hirsutism or virilization (Virilization is when a female develops male sex characteristics) point to other diagnosis, such as an androgen producing tumor.

 

Obesity:

§  Tables of percentiles (P) for BMI should be used as they are the only correct way to identify obesity and over weight in this age group. Obesity is defined when BMI is above the 95th percentile and overweight when BMI is between the 85th and 95th percentiles for age and sex.

 

Hyperandrogenism:

§  Hirsutism: Hirsutism is defined as the presence of terminal hair that appears excessively in a male pattern in women. Terminal hair is the thick, long and pigmented hair that normally exists in the pubic and axillary areas after puberty. One must distinguish between hirsutism and hypertrichosis.

 

erminal hair is longer, coarser, and darker than vellus hair

 

Hypertrichosis is a condition of excessive hair growth in a generalized distribution that can be inherited or secondary to the use of certain drugs. In the assessment of hirsutism it is important to know the treatments previously carried out to remove hair. Even taking in to account its limitations, the Ferriman–Gallwey scale (Figure1) is useful to confirm and monitor hirsutism. According to the Endocrine Society guidelines published in 2008 Hirsutism is indicated by a Ferriman–Gallwey hirsutism score >8.

 

Hirsutism equivalents:

Hirsutism and its equivalents represent manifestations of excess androgens that are present in 2/3 of women with biochemical hyperandrogenism. Not all hirsutismis caused by hyperandrogenism. About ½ of women with mild hirsutism and 1/6 of those with moderate hirsutism donot have hyperandrogenism. PCOS is the most common cause of hyperandrogenemia. Other causes are rare: They are Non-classic congenital adrenal hyperplasia, Androgen-secreting tumors, hyperprolactinemia, and Cushing’s syndrome, acromegaly and thyroid dysfunction.

 

Menstrual irregularities:

Menstrual cycles of adolescents, especially in the first year after menarche, may be anovulatory and irregular. However, it is a myth that they are completely chaotic. By the third year after menarche, 95% of menstrual cycles have an expected duration between 21 and 45 days and the bleeding lasts 2 to 7 days. Menstrual irregularities that remain 2 years after menarche are associated with PCOS in about 70% of cases.

 

A menstrual flow greater than 80mL per cycle or a subjective impression of heavier than normal flow (more than 6 full pads or tampons per day) is considered abnormal. Abnormal uterine bleeding is among the most frequent complaints of adolescents. The majority of cases related to anovulatory cycles in the first 12–18 months after menarche due to immaturity of the hypothalamic–pituitary–ovarian axis also called dysfunctional uterine bleeding. Other causes include pregnancy, oral contraceptives and endocrine disorders (PCOS, hypothyroidism, hyperprolactinemia).

 

Diagnosis:

 

 Typically this evaluation includes the following tests.

·         Pnancy test, if amenorrhoea.

 

·         Pelvic ultrasound.  - Bilaterally enlarged cystic ovaries with > 8 follicles per ovary, with less than 10 mm in diameter. > 90 % of PCOS - present in USG. Multiple follicles - ‘‘string of pearls’’ on USG. Transvaginal approach has allowed better delineation of multiple follicular cysts.

 

·         Prolactin to exclude hyperprolactinemia. It can manifest with oligomenorrhea or amenorrhea and / or galactorrhea. 

 

·         DHEAS (Dehydro Epiandrosteron Sulphate – secreted by adrenal glands- evaluate adrenal gland function) and

17- OH – progesterone (between 7 and 8 a.m.) in the follicular phase of the menstrual cycle to exclude adrenal hyperandrogenism. 

 

·         Assessment for Cushing’s syndrome, thyroid dysfunction or growth hormone excess, if other clinical features are present:

 

·         TSH if menstrual irregularities, symptoms or signs of thyroid dysfunction.

 

·         Insulin-like growth factor 1(IGF-1) if growth hormone excess is suspected.

 

·         Urinary free cortisol (24-hurine) if hyperandrogenism, menstrual irregularities, violaceous striae (wider than 1cm striae in the abdomen-manifestation of Cushing’s syndrome), central obesity.

 

 


Ferriman–Gallwey hirsutism scoring system. Each of the nine body areas most sensitive to androgen is assigned a score from 0 (no hair) to 4 (frankly virile), and these separate scores are summed to provide a hormonal hirsutism score. [Reproduced from Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline].

 

 

 


Some extremely rare cases will be clarified only with more specific tests such as dexamethasone suppression or Corticotropin (ACTH) stimulation tests, as suggested by the American Society for Reproductive Medicine.

 

For confirmation of anovulation, measurement of progesterone between the 22th and 24th days of menstrual cycle can be useful.

 

Additional:

Other tests should be considered according to the clinical picture. In the presence of rapidly progressive hirsutism or signs of virilization, computed tomographic scans (CT) or magnetic resonance imaging (MRI) of adrenal glands are also essential for diagnosis of an adrenal tumor. As women with PCOS are particularly prone to develop metabolic syndrome (MS), we must not forget to measure blood pressure, waist circumference, fasting glucose and lipid profile and to perform an oral glucose tolerance test (OGTT).

 

Thus, in the presence of PCOS, OGTT should be performed even in the presence of a normal fasting glucose, regardless of the presence of obesity. These are also the recommendations of the American Society for Reproductive Medicine published in late 2008.

Treatment:

Rounded Rectangle: Polycystic ovary disease requires "control" rather than "cure" and treatment depend on symptoms, age, and desire to become pregnant
 

 

 

 

 


The treatment of adolescents with PCOS has focused on short-term aspects. The goal of treatment is not related to infertility in this age group. Short -term aspects such as self-esteem, acne and hirsutism improvement, weight control and menstrual cycles regulation. It is important, however, to stress that the treatment should also take into account long-term aspects such as reducing the risk of type 2 diabetes mellitus and cardiovascular disease.

 

The treatment should be individualized according to co- morbid conditions (e.g. obesity) and the goals to be achieved. Given the strong evidence that hyperinsulinemia plays a key role in the pathogenesis of PCOS, targeted interventions aiming changes in lifestyle are essential. Weight reduction with dietary interventions is effective in reducing androgens levels and in regulating menstrual cycles.

 

Reduction of testosterone concentrations and regulation of menstrual cycles are associated with losses of about 5–7% of bodyweight. Above all, changes in lifestyle are the cornerstone of treatment to reduce the risk of type 2 diabetes mellitus and cardiovascular disease.

Medical Therapy:

Oral contraceptives:

For most pediatric endocrinologists, oral contraceptives are considered first-line drugs in the treatment of adolescents with PCOS.

 

The menstrual irregularities should be treated, as chronic anovulation increases the risk of endometrial hyperplasia, which is associated with endometrial carcinoma. Moreover, in some cases, dysfunctional bleeding or menorrhagia can lead to anemia.

 

The estrogenic component suppresses LH and thus production of androgens by ovaries and increases production of SHBG, resulting in lower concentrations of free testosterone.

 

The estrogenic component suppresses LH and production of androgens by ovaries, Increases production of SHBG, Lower concentrations of free testosterone.

 

Estroprogestatives also inhibits 5-alpha-reductase in the skin, lowering levels of dihydrotestosterone. There is a normalization of androgen levels in18–21 days of treatment in most cases. There is a normalization of androgen levelsin18–21 days of treatment in most cases. Estroprogestatives can be used with 30–35 mg or lower doses of 20 mg of ethinyl estradiol for improvement of hyperandrogenism.  Both preparations appear to be similar in terms of effectiveness atleast regarding the improvement of acne.

 

Anti-androgens:

o    Used to control the growth of terminal hair

o    It may take 9–18 months of treatment to check effects

o    Cyproterone acetate

o    Spironolactone - dose of 50 mg bid, 100 mg bid for a greater effect.

o    Flutamide

o    Finasteride - 5 alpha reductase type 2 inhibitor

 

There is only limited information about the use of Flutamide and Finasteride in adolescence.

 

Metformin in adolescents with polycystic ovary syndrome:

Oral contraceptives donot address and may even worsen metabolic complications of PCOS, although these data are controversial.

—  It inhibits hepatic glucose production and improves sensitivity of peripheral tissues to insulin.

—  It also decreases appetite and promotes weight loss.

—  It inhibits hepatic glucose production and improves sensitivity of peripheral tissues to insulin.

—  Metformin improves insulin levels, reduces androgens and regulates menstrual cycles in patients with PCOS, not only in adulthood, but also in adolescence.

—  Metformin may be beneficial in some children even before menarche.

—  Glitazones replace metformin

—  Studies in children with premature pubarche and a history of low birth weight demonstrated the efficacy of metformin in delaying menarche.

—  Some studies have shown the effectiveness of metformin in preventing PCOS progression for non-obese individuals with a history of low birth weight and premature pubarche.

—  Improved metabolic profile disappeared after discontinuation of therapy in these adolescents.

—  In a study of obese adolescents with PCOS, metformin has been effective in improving menstrual cycles, decreasing androgens, improving hirsutism and acne, and in weight reduction, and these effects persisted 6 months after discontinuation.

 

According to the recommendations of the American Society for Reproductive Medicine

·         Adolescents with PCOS should perform an OGTT every 2 years for screening glucose tolerance abnormality;

·         Metformin may be considered in patients with PCOS and abnormal glucose tolerance;

·         Donot have to recommend metformin as first-line therapy in PCOS when the sole purpose is to prevent long-term complications such as T2 DM or cardiovascular disease; in the mean - while, lifestyle changes should take that place;

·         The first-line therapy for ovulation induction in patients with PCOS who wish to become pregnant is clomiphene citrate, and combination with metformin can be useful in refractory cases.

 

Cosmetic Treatments:

Patients often want to be counseled about permanent hair removal. Techniques commonly referred to as ‘‘permanent hair removal’’ are the hair removal laser/pulsed light and electrolysis. Topical eflornithine, which slows hair growth, is approved by the Food and Drug Administration (FDA) for reduction of unwanted facial hair in women.

 

Topical treatments for acne can be used in combination with oral contraceptives. Topical retinoids are indicated in all types of acne. Topical antibiotics such as benzoyl peroxide have been helpful in mild to moderate inflammatory acne. Oral isotretinoin is associated with several side effects and has a high teratogenic potential that remains at 6 weeks after completion of treatment; it is reserved for severe cases.

 

Dietary Guidelines to Combat PCOS :

A few dietary guidelines to combat PCOS

1.       Try to select lower glycemic index foods such as whole grains (jowar, bajra, whole wheat, green vegetables, etc) as they will cause a slower rise in blood sugar levels. For example, oat flakes or wheat daliah (10 gm fiber/1/2 cup) has a lower glycemic index than cornflakes (1 gm fiber/1/2 cup). Simply put, add fiber in diet by selecting wheat breads over white breads, wheat rotis over rice or maida naans, fresh fruits over fruit juices.

2.       Do cut down carbohydrate levels so low level of ketosis induced. Try to space the carbohydrates evenly through the day and eat small and frequent meals rather than 3 large meals.

3.       Restrict intake of those carbohydrates that trigger more hunger or cravings (i.e. refined sugar, sweets, candies or chocolates which triggers craving for some people). Choose dates or honey to meet sugar cravings.

4.       Suggested vitamin / mineral supplements: Taking calcium 1000 mg - 1500 mg (take two - three 500 mg pills a day as prescribed but be sure to space them out as only absorb 500 mg at a time). Add a multivitamin with minerals like folic acid, especially so, if trying to get pregnant.

5.       Drink at least 8-10 glasses of water per day as a high fiber carbohydrate intake can cause dehydration.

6.       For heart health, limit foods high in saturated and trans-fats (i.e., whole milk and products, butter, red meat, fried foods, rich desserts, etc.). Select mainly monounsaturated fats (i.e. olive oil, canola oil, nuts) and omega 3 fats -fatty fish (such as bangda, rohu, sardines, and surmai), flaxseed, and nuts as these fats are heart friendly.

 

Prognosis:

Rounded Rectangle: Polycystic ovary syndrome may be regarded as a disorder that progresses until the time of menopause unless it is treated
 

 

 

 


Untreated polycystic ovary syndrome may be regarded as a disorder that progresses until the time of menopause. The long-term consequences for PCOS are - Infertility, Recurrent spontaneous abortion, Depression/anxiety, Abnormal lipid levels (Dyslipidemia), Hypertension, Type 2 diabetes mellitus, Coronary artery disease, Cerebrovascular accidents, Endometrial cancer.

 

PCOS maybe exist in three forms – mild, moderate and severe and the prognosis varies accordingly. In the mild forms of PCOD, the affected woman may have - No abnormality of menstruations and may ovulate normally. It often takes these women longer than normal to conceive and has a higher chance of spontaneous miscarriage. In moderate PCOD – There are menstrual irregularities or absence of menstruation and failure of ovulation. The most severe form of PCOD is characterized by- Obesity, hirsutism, amenorrhea and infertility.

 

Possible Nursing Diagnosis of PCOS:

—  Disturbed body image – hirsutism, male features

—  Sexual dysfunction – menstrual irregularities

—  Impaired tissue integrity – Acne, acanthosis nigricans

—  Ineffective health maintenance – obesity

—  Risk for Imbalanced nutrition more than body requirement – obesity, Type2 DM

—  Ineffective coping

—  Disturbed personal identity

—  Ineffective sexuality pattern (female)

—  Risk for situational low self-esteem

—  Risk for unstable blood glucose

—  Readiness for enhanced nutrition

—  Readiness for enhanced hoping

—  Readiness for enhanced therapeutic management

—  Readiness for enhanced resilience

—  Knowledge deficit

 

CONCLUSION:

PCOS is a common disease among adolescents and has been increasingly associated with metabolic and cardiovascular complications in the long term, going beyond cosmetic and fertility concerns. The prevalence of obesity is increasing, thereby aggravating the symptoms of these adolescents. The control of obesity and overweight is essential and should begin as early as possible.

 

PCOS may remain unnoticed because symptoms such as menstrual irregularities and acne are relatively common, with an overlap between symptoms of the syndrome and physiological changes of puberty. Changes in lifestyle are the first-line therapy. Depending on symptoms and presence of glucose intolerance, therapeutic weapons include oral contraceptives, anti-androgens and metformin, but more studies are needed to clarify the best strategy in the prevention of metabolic complications in the long term.

 

 

REFERENCES:

1.        Ana O et al. Polycystic ovary syndrome: Challenges in adolescence. Endocrinología Nutrition. 57(7); 2010:328-336.

2.        Boyle J. Polycystic ovary syndrome and associated metabolic features in Indigenous women in the Northern Territory [PhD thesis]. Adelaide: University of Adelaide, 2011.

3.        Ching H, Burke V, Stuckey B. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clinical Endocrinology (Oxf). 66: 2007: 373-379.

4.        Cibula D, Hill M, Starka L. The best correlation of the new index of hyperandrogenism with the grade of increased body hair. Europian Journal of Endocrinology. 143: 2000:405-408.

5.        De Simone M, Verrotti A, Iughetti L, et al. Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin levels in massively obese adolescent girls. Journal of Endocrinological Investigation. 24; 2001:438-444.

6.        Deeks A, Gibson HM, Teede H. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertility and Sterility. 93; 2010: 2421-2423.

7.        Dr. Michael F C. et al. Assessment and management of polycystic ovary syndrome: summary of an evidence based guideline. Medical journal of Australia, 195 (6); 2011: 65.

8.        Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews. ; 18; 1997:774-800.

9.        Ehrmann DA. Polycystic ovary syndrome. The New England Journal of  Medicine. 352;2005:1223-1236.

10.     Eisenhardt S, Schwarzmann N, Henschel V, et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 91; 2006:946-952.

11.     Glueck CJ, Wang P, Fontaine R, et al. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). Journal of Adolescent Health. 29; 2001:160-169.

12.     Helena JT et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. The Medical Journal of Australia. 195 (6); 2011: S65-S112.

13.     Hillard PJ. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents. Endocrinology and Metabolism Clinics of North America. 34; 2005:707-723.

14.     Jonard S, Robert Y, Cortet C, et al. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Human Reproduction. 18; 2003:598-603.

15.     March W, Moore V, Willson K, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction. 2010; 25: 544-551.

16.     McCartney CR, Prendergast KA, Chhabra S, et al. The association of obesity and hyperandrogenemia during transition in girls: obesity as a potential factor in the genesis of post pubertal hyperandrogenism. The Journal Clinical Endocrinology and Metabolism. 91; 2006:1714-1722.

17.     Moran L et al. Polycystic ovary syndrome: a bio-psychosocial understanding in young women to improve knowledge and treatment options. The Journal of Psychosomatic Obstetrics and Gynecology. 31; 2010: 24-31.

18.     Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human Reproduction Update.15; 2009: 477-488.

19.     Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 16; 2010: 347-363.

20.     Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex conditions with psychological, reproductive and metabolic manifestations that impact on health across the lifespan. BMC Medicine.8; 2010 8: 41.

21.     Trent ME, Rich M, Austin SB, et al. Quality of life in adolescent girls with polycystic ovary syndrome. Archieves of Pediatric and Adolescent Medicine. 156; 2002:556-560.

22.     Monso kohli . How to tackle PCOS Women’s health: 2011.

23.     http://www.aafp.org/afp/20030815/697.html

24.     http://www.aafp.org/afp/20000901/1079.html

25.     http://familydoctor.org/620.xml

26.     http://www.emedicine.com/radio/topic565.htm

27.     http://www.inciid.org/faq.php?cat=infertility101

28.     http:// www.modernmedicine.com

29.     http:// www.indiaparenting.com

 

 

 

Received on 17.05.2012          Modified on 22.05.2012

Accepted on 25.05.2012          © A&V Publication all right reserved

Asian J. Nur. Edu. & Research 2(2): April-June 2012; Page 55-64